Clinical Studies

Ongoing Studies

NYX-783

Phase 2 – Post-Traumatic Stress Disorder

A first-in-patient, randomized, double-blind, placebo-controlled, study to evaluate the safety and efficacy of NYX-783 in subjects with post-traumatic stress disorder — For more information, visit www.clinicaltrials.gov